Longitudinal Decline in Kidney Graft Function Following COVID‐19 in Kidney Transplant Recipients

Read full text Summarise with VIRAT
Authors: Joe Lebbos, Akel Azzi, Pierre Kassis, Dania Nehme Chelala
Cited by: 0
References: 5

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

To the Editor, Kidney transplant recipients (KTRs) are particularly vulnerable during the coronavirus disease 2019 (COVID-19) due to chronic immunosuppression and comorbidities. While acute kidney injury during COVID-19 has been well described, data on long-term graft function trajectories remain limited, particularly in patients with mild disease. We conducted a single-center retrospective study of 52 KTRs diagnosed with COVID-19 between 2020 and 2022 at the Hôtel Dieu de France University Hospital in Beirut, Lebanon (approved by the Ethics Committee of the Faculty of Medicine at Saint Joseph University, Tfem/2023/48). Serial serum creatinine measurements were available for 12 months before and after infection. COVID-19 severity was predominantly mild (79%), with fewer patients experiencing moderate, severe, or critical illness. Using linear mixed-effects models to account for repeated measures, we observed a significant increase in creatinine following COVID-19. The adjusted mean creatinine rose from 1.18 mg/dL (95% CI, 1.16–1.20) pre-infection to 1.41 mg/dL (95% CI, 1.39–1.44) post-infection (p < 0.001). Similar results were seen when comparing the last pre-infection and last post-infection measurements. Importantly, this association persisted even among patients with mild COVID-19, suggesting that clinically mild infection may still impact long-term graft function (Table 1). Exploratory univariate analyses showed that older age (> 50 years) and longer graft duration were associated with graft function decline (OR 2.28 and 2.59, respectively; p < 0.01). Although graft function naturally declines over time, the within-patient longitudinal design suggests that the post-COVID-19 decline exceeds expected pre-infection trajectories. Our findings align with emerging literature. Malinowska et al. reported modest post-COVID-19 graft function changes over 1 year [1], while Caillard et al. highlighted increased morbidity and mortality among KTRs without assessing graft function [2]. This study extends these observations by demonstrating measurable long-term effects even after mild infection. Potential mechanisms include endothelial injury, microvascular thrombosis, and immune dysregulation, though causal inference is limited by the observational design [3-5]. Limitations include the retrospective single-center design, small sample size, and lack of a non-COVID KTR control group. Residual confounding from immunosuppressive adjustments or comorbidities cannot be excluded. Despite these limitations, repeated within-patient measurements provide a robust assessment of longitudinal graft function. In conclusion, COVID-19 may be associated with a sustained decline in kidney graft function, even after mild infection. These findings support close post-COVID-19 monitoring of KTRs and underscore the need for larger, prospective studies with control groups to better define long-term graft outcomes. The authors have nothing to report. The study was approved by the Ethics Committee of the Faculty of Medicine at Saint Joseph University (Tfem/2023/48). The authors declare no conflicts of interest.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments COVID-19 Clinical Research Studies Long-Term Effects of COVID-19

Publication details

Journal / source
Transplant Infectious Disease
Volume
28
Issue
3
Pages
e70211–e70211
Publication date
31 March 2026
Language
EN